---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-358541"
form_type: "8-K"
ticker: "RGEN"
cik: "0000730272"
company_name: "REPLIGEN CORP"
filed_at: "2021-12-16T23:59:59+00:00"
generated_at: "2026-06-28T00:41:53.933835+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "medium"
source: SEC EDGAR
---

# Repligen acquires Bio-Flex Solutions and Newton T&M for cash; terms undisclosed

## Summary
- Acquired all outstanding equity interests in Bio-Flex Solutions and Newton T&M effective Dec 16, 2021.
- Purchase price is cash consideration; no dollar amount disclosed in the filing.
- Bio-Flex Solutions specializes in single-use flexible containers and tubing assemblies for biopharma.
- Transaction complements Repligen's fluid management portfolio; investor presentation provided.

## SEC filing metadata
- accession: 0001193125-21-358541
- form_type: 8-K
- ticker: RGEN
- cik: 0000730272
- company_name: REPLIGEN CORP
- filed_at: 2021-12-16T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: medium
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/730272/000119312521358541/0001193125-21-358541-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/730272/000119312521358541/d242360d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-358541
- JSON: https://secwatch.observer/filing/0001193125-21-358541.json
- Plain text: https://secwatch.observer/filing/0001193125-21-358541.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.